Results 151 to 160 of about 42,297 (231)

Antinuclear antibodies in early multiple sclerosis reflect systemic lupus erythematosus shared risk factors. [PDF]

Sci Rep
Corsten CEA, Marques AM, Masmanidou D, Ikram MK, van Luijn MM, Wokke B, Smolders J.   +6 more
europepmc   +1 more source

Fn14 signalling participates in pristane‐induced murine lupus through exacerbating oxidative stress

British Journal of Pharmacology, Volume 183, Issue 16, Page 5102-5119, August 2026.
Background and Purpose Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by oxidative stress and immune dysregulation. Fibroblast growth factor‐inducible 14 (Fn14) has been implicated in tissue injury, but its specific role in SLE pathogenesis remains unclear.
Zhu Yan, Rongfang Feng, Mai Luo, Yaqi Wang, Min Gao, Qin Chen, Yufei Zhang, Yale Liu, Yumin Xia   +8 more
wiley   +1 more source

Associations between functional autoantibodies targeting GPCRs, antinuclear antibodies, and inflammatory cytokines TNF-α: a cross-sectional study of 19,810 individuals. [PDF]

Front Immunol
Chen X, Kieselbach B, Krämer BK, von Baehr V, Reichetzeder C, Hocher B.   +5 more
europepmc   +1 more source

Interleukin‐40 in Systemic Sclerosis: A Treatment‐Sensitive Marker of Immune Modulation Rather Than Disease Activity

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT Interleukin‐40 (IL‐40) is a recently identified cytokine primarily produced by activated B cells and implicated in immune regulation across several autoimmune diseases. Although B cell–driven immune dysregulation plays a central role in systemic sclerosis (SSc), the circulating behavior and clinical relevance of IL‐40 in this disease remain ...
İbrahim Vasi, Emin Ümit Bağrıaçık, Rıza Can Kardaş, Nihan Örüklü, Melek Yaman, Derya Yıldırım, Burcugül Kaya, Rahime Duran, İbrahim Karaduman, İbrahim Yahya Çakır, Hamit Küçük, Berna Göker, Abdulsamet Erden, Mehmet Akif Öztürk   +13 more
wiley   +1 more source

Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States. [PDF]

Front Immunol
Dinse GE, Weinberg CR, Parks CG, Co CA, Priest JT, Chan EKL, Miller FW.   +6 more
europepmc   +1 more source

Antinuclear antibodies as a risk factor for ischemic stroke or death in elderly patients with atrial fibrillation despite anticoagulation. [PDF]

Clin Rheumatol
Hanarz M, Ząbczyk M, Natorska J, Pociask E, Undas A.   +4 more
europepmc   +1 more source

Differences in Dynamics of Specific Antinuclear Antibodies and Their Susceptibility to B Cell-Targeting Treatment in Patients With Systemic Lupus Erythematosus. [PDF]

Arthritis Rheumatol
van Dooren HJ, van Schaik M, Dorjée AL, Arends EJ, Mackay M, Cooney L, Fox DA, Wofsy D, Smilek D, Aranow C, Dall'Era M, Huizinga TWJ, van Kooten C, Toes REM, Diamond B, Teng YKO, Suurmond J.   +16 more
europepmc   +1 more source

Prevalence of Antinuclear Antibodies in Patients With Coronary Artery Disease: A Scoping Review. [PDF]

Cureus
Antony M, Thymalil C, Nagy S, Amini K, Kesselman MM.   +4 more
europepmc   +1 more source

Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients. [PDF]

Hum Reprod
Yoshihara H, Goto S, Kitaori T, Sugiura-Ogasawara M.   +3 more
europepmc   +1 more source

Dietary Fatty Acids and Antinuclear Antibodies Among Adults with Arthritis in the United States: NHANES 1999-2004. [PDF]

Nutrients
Guo J, Yu Y, Su J, Ren F, Chen J.
europepmc   +1 more source